- The Human Brain Project’s promotional video was shared and criticized for its heavy use of stock footage and perceived lack of clarity about the project’s scientific direction.  
- Discussion of ribosome display as an in-vitro protein-evolution technique that links translated proteins to their mRNA templates for high-throughput binding assays.  
- A Stanford 2015 study on telomere extension in cultured cells was raised; participants questioned why the approach has not yet been translated to in-vivo human skin applications.  
- Libella Gene Therapeutics’ plan to run a 5-person, $900 k-per-participant AAV-hTERT trial in Colombia under local IRB approval sparked debate on whether the price reflects genuine trial costs or profit-taking.  
- John Carmack’s announcement that he will personally work on artificial general intelligence was noted, with skepticism about the feasibility of solo progress in AGI.  
- A ribosome was cited as an existing molecular assembler, prompting speculation on whether future nanoscale assemblers could enable open-source hardware ecosystems analogous to open-source software.  
- Netflix’s “Unnatural Selection” documentary series (and the related 2019 film “Human Nature”) were recommended as recent media covering CRISPR, DIY bio, and regulatory controversies.  
- A biology-lab anecdote described running Windows XP drivers inside a VM, crashing the VM to force a core dump, and extracting experimental data as the only viable workflow—highlighting persistent automation and legacy-software problems in research.